Oramed Pharmaceuticals (ORMP) Research & Development (2011 - 2026)
Oramed Pharmaceuticals (ORMP) posted Research & Development of $1.6 million for Q1 2026, down 19.82% on a QoQ basis from $2.0 million in Q4 2025, and down 27.74% year-over-year from $2.2 million in Q1 2025.
Oramed Pharmaceuticals (ORMP) Research & Development (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Research & Development history runs 15 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- Quarterly Research & Development fell 27.74% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (down 21.52% YoY) and the FY2025 annual result came in at $6.4 million, up 0.9% from the prior year.
- Research & Development was $1.6 million for Q1 2026 at Oramed Pharmaceuticals, down from $2.0 million in the prior quarter.
- Across five years, Research & Development topped out at $9.0 million in Q4 2022 and bottomed at $380000.0 in Q2 2022.
- A 5-year average of $2.3 million and a median of $1.6 million in 2026 frame the typical range for Research & Development.
- Peak annual rise in Research & Development reached 379.21% in 2023, while the deepest fall reached 80.46% in 2023.
- Oramed Pharmaceuticals' Research & Development stood at $9.0 million in 2022, then slumped by 80.46% to $1.8 million in 2023, then dropped by 17.27% to $1.5 million in 2024, then jumped by 36.07% to $2.0 million in 2025, then fell by 19.82% to $1.6 million in 2026.
- Business Quant data shows ORMP's Research & Development at $1.6 million in Q1 2026, $2.0 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | 1.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | 1.99 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 2.24 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 957,000.00 |
| Jun 30, 2023 | 1.82 Mn |
| Mar 31, 2023 | 4.43 Mn |
| Dec 31, 2022 | 9.04 Mn |
| Sep 30, 2022 | 463,000.00 |
| Jun 30, 2022 | 380,000.00 |
| Mar 31, 2022 | 5.84 Mn |
| Aug 31, 2021 | 20.99 Mn |
| Nov 30, 2019 | 2.02 Mn |
| Aug 31, 2019 | 2.20 Mn |